Investing News Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer January 25, 2023
Trading Tips Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda January 4, 2023
Investing News Merck Stock Flattens as Ranked the Best-performing Major American Pharmaceutical in 2022 December 30, 2022
Investing News Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff December 2, 2022
Investing News Merck Stock Price Rose as the Company Raised Its Full-Year Outlook Due to the Success of Keytruda October 27, 2022
Investing News Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda October 27, 2022
Investing News Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth. October 10, 2022